304 related articles for article (PubMed ID: 38312128)
1. Mechanisms and therapeutic strategies to combat the recurrence and progression of hepatocellular carcinoma after thermal ablation.
Ye F; Xie L; Liang L; Zhou Z; He S; Li R; Lin L; Zhu K
J Interv Med; 2023 Nov; 6(4):160-169. PubMed ID: 38312128
[TBL] [Abstract][Full Text] [Related]
2. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
[TBL] [Abstract][Full Text] [Related]
3. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
4. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
[TBL] [Abstract][Full Text] [Related]
5. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
[TBL] [Abstract][Full Text] [Related]
6. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
[TBL] [Abstract][Full Text] [Related]
7. A well-matched marriage of immunotherapy and radiofrequency ablation to reduce the relapse and progression of hepatocellular carcinoma.
Liao R; Song P; Duan Y; Ye W; Yin K; Kang M; Yu Y; Yang J; Tang W
Biosci Trends; 2022 Nov; 16(5):377-380. PubMed ID: 36089338
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency versus microwave ablation for management of hepatocellular carcinoma: a randomized controlled trial.
Kamal A; Elmoety AAA; Rostom YAM; Shater MS; Lashen SA
J Gastrointest Oncol; 2019 Jun; 10(3):562-571. PubMed ID: 31183208
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.
Cao S; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J; Zou Y
Cancer Imaging; 2022 Jan; 22(1):2. PubMed ID: 34983650
[TBL] [Abstract][Full Text] [Related]
11. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation.
Shi ZR; Duan YX; Cui F; Wu ZJ; Li MP; Song PP; Peng QL; Ye WT; Yin KL; Kang MQ; Yu YX; Yang J; Tang W; Liao R
J Exp Clin Cancer Res; 2023 May; 42(1):133. PubMed ID: 37231509
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma.
Wada T; Sugimoto K; Sakamaki K; Takahashi H; Kakegawa T; Tomita Y; Abe M; Yoshimasu Y; Takeuchi H; Itoi T
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765689
[TBL] [Abstract][Full Text] [Related]
13. LncRNA FUNDC2P4 down-regulation promotes epithelial-mesenchymal transition by reducing E-cadherin expression in residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Zeng J; Cai X; Hao X; Huang F; He Z; Sun H; Lu Y; Lei J; Zeng W; Liu Y; Luo R
Int J Hyperthermia; 2018 Sep; 34(6):802-811. PubMed ID: 29295626
[TBL] [Abstract][Full Text] [Related]
14. Epithelial-mesenchymal transition-related genes are linked to aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation.
Iwahashi S; Shimada M; Utsunomiya T; Imura S; Morine Y; Ikemoto T; Takasu C; Saito Y; Yamada S
Cancer Lett; 2016 May; 375(1):47-50. PubMed ID: 26940140
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for hepatocellular carcinoma following thermal ablation.
Li X; Liang P
J BUON; 2014; 19(4):867-71. PubMed ID: 25536588
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.
Izzo F; Granata V; Grassi R; Fusco R; Palaia R; Delrio P; Carrafiello G; Azoulay D; Petrillo A; Curley SA
Oncologist; 2019 Oct; 24(10):e990-e1005. PubMed ID: 31217342
[TBL] [Abstract][Full Text] [Related]
17. Thermal ablation and immunotherapy for hepatocellular carcinoma: Recent advances and future directions.
Bo XW; Sun LP; Yu SY; Xu HX
World J Gastrointest Oncol; 2021 Oct; 13(10):1397-1411. PubMed ID: 34721773
[TBL] [Abstract][Full Text] [Related]
18. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Tan W; Deng Q; Lin S; Wang Y; Xu G
Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous microwave ablation versus radiofrequency ablation of hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Yu Q; Liu C; Navuluri R; Ahmed O
Abdom Radiol (NY); 2021 Sep; 46(9):4467-4475. PubMed ID: 33870454
[TBL] [Abstract][Full Text] [Related]
20. Effect of a hypoxic microenvironment after radiofrequency ablation on residual hepatocellular cell migration and invasion.
Tong Y; Yang H; Xu X; Ruan J; Liang M; Wu J; Luo B
Cancer Sci; 2017 Apr; 108(4):753-762. PubMed ID: 28182306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
